KLI
Login
OAK 국가리포지터리
검색
커뮤니티
제목
저자
키워드
발행일
Ulsan Univ. Repository
Browsing by 저자 : Jin-Hee Ahn
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
또는 첫 단어:
정렬 기준:
제목
발행일
제출일
정렬:
오름차순
내림차순
결과 수
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
저자 수
All
1
3
5
10
15
20
25
30
35
40
45
50
전체 결과 11건 중 1-11 번을 표시중입니다.
1
Article
A Propensity Score-matched Analysis of Long-term Oncologic Outcomes After Nipple-sparing Versus Conventional Mastectomy for Locally Advanced Breast Cancer
Zhen-Yu Wu
;
Hyun Ho Han
;
Hee Jeong Kim
;
et al
2022
2
Article
Association between tumor 18 F-fluorodeoxyglucose metabolism and survival in women with estrogen receptor-positive, HER2-negative breast cancer
Sun Young Chae
;
Seol Hoon Park
;
Hyo Sang Lee
;
et al
2022
3
Article
Clinicopathologic Characteristics and Clinical Outcome of Localized Liposarcoma: A Single-Center Experience over 25 Years and Evaluation of PD-L1 Expression
Heejung Chae
;
Jeong Eun Kim
;
Wanlim Kim
;
et al
2022
4
Article
Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor?Positive, HER2-Negative Metastatic Breast Cancer
Hyehyun Jeong
;
Jae Ho Jeong
;
Jeong Eun Kim
;
et al
2022
5
Article
CT Findings From Interstitial Lung Diseases in Patients With Metastatic Breast Cancer Treated With Fam-Trastuzumab Deruxtecan: A Single Institutional Experience
Yoon Jung Jang
;
Jae Ho Jeong
;
Jeong Eun Kim
;
et al
2022
6
Article
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer
Peter Schmid
;
Javier Cortes
;
Rebecca Dent
;
et al
2022
7
Article
Pathological complete response, long-term outcomes, and recurrence patterns in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy
Sora Kang
;
So H Lee
;
Hee J Lee
;
et al
2022
8
Article
Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma
Chang Gon Kim
;
Nam Suk Sim
;
Jeong Eun Kim
;
et al
2022
9
Article
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer
Hee Kyung Ahn
;
Sung Hoon Sim
;
Koung Jin Suh
;
et al
2022
10
Article
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study
Jwa Hoon Kim
;
Seyoung Seo
;
Jee Hyun Kim
;
et al
2022
11
Article
Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study
Joonha Kwon
;
Jun Hyeong Lee
;
Young Han Lee
;
et al
2022
1
Anonymous
Login
커뮤니티
제목
저자
키워드
발행일
Guide